The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Innophos Holdings Inc

Nasdaq: IPHS
Last

(U.S.) $49.43

Today's change+0.38 +0.77%
Updated October 20 4:00 PM EDT. Delayed by at least 15 minutes.
 

Innophos Holdings Inc

Nasdaq: IPHS
Last

(U.S.) $49.43

Today's change+0.38 +0.77%
Updated October 20 4:00 PM EDT. Delayed by at least 15 minutes.

Innophos Holdings Inc crosses above 20-day moving average

Innophos Holdings Inc closed up Friday by (U.S.)$0.38 or 0.77% to (U.S.)$49.43 and crossing above its 20-day moving average. Over the last five days, shares have lost 0.46% and are down 5.42% for the last year to date. This security has underperformed the S&P 500 by 2.40% during the last year.

Key company metrics

  • Open(U.S.) $49.48
  • Previous close(U.S.) $49.05
  • High(U.S.) $49.55
  • Low(U.S.) $49.10
  • Bid / Ask-- / --
  • YTD % change-5.42%
  • Volume51,958
  • Average volume (10-day)91,530
  • Average volume (1-month)92,166
  • Average volume (3-month)101,927
  • 52-week range(U.S.) $39.52 to (U.S.) $58.22
  • Beta0.86
  • Trailing P/E21.65×
  • P/E 1 year forward19.73×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $1.92
  • Dividend yield3.88%
  • Trailing EPS(U.S.) $2.28
Updated October 20 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+6.46%

Based on its net profit margin of 6.46%, Innophos Holdings Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.25%Sector:Basic MaterialsIndustry:Chemicals - Commodity

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue179166168186
Total other revenue--------
Total revenue179166168186
Gross profit39373341
Total cost of revenue140129135145
Total operating expense161150151164
Selling / general / administrative20191618
Research & development1111
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income18161622
Interest income (expense), net non-operating-2-1-2-2
Gain (loss) on sale of assets--------
Other--------
Income before tax17151420
Income after tax1111914
Income tax, total6446
Net income1111914
Total adjustments to net income0000
Net income before extra. items1111914
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1111914
Inc. avail. to common incl. extra. items1111914
Diluted net income1111914
Dilution adjustment--------
Diluted weighted average shares20202020
Diluted EPS excluding extraordinary itemsvalue per share0.570.550.480.69
Dividends per sharevalue per share0.480.480.480.48
Diluted normalized EPSvalue per share0.570.550.480.69